The Solesis Team

John Witkowski joined Solesis in 2024 as the President & CEO. He is responsible for developing the strategic priorities for Solesis and executing world-class business operations to support customers and drive long-term, sustainable growth.

With close to 30 years of experience across the medical device and biopharmaceutical industries, John has extensive experience in leading organizations through periods of significant growth and innovation. Most recently, he served as the President of DSM Biomedical, the global biomaterials division of dsm-firmenich. His strong track record of growth, both organically and via Mergers & Acquisitions, positions Solesis to achieve long-term, sustainable growth.

John holds a Bachelor’s degree in Industrial Engineering from Georgia Institute of Technology and a MBA from Iona College. He currently is a Board member for PA Life Sciences and Unshattered, a non-profit organization focused on ending the addiction relapse cycle.

Gersen Gabriel joined Solesis in 2024 as the Chief Operating Officer. He is responsible for the strategy and direction for our Operations team, the Facilities/Maintenance departments, Supply Chain, BioMaterials Engineering and SanaVita Medical.

He brings a proven record of success in Lean Manufacturing, Value Stream Mapping, Kaizen Methodology, and EBITDA growth plan execution in the medical device and life sciences space. Gersen has more than 15 years of experience and leadership across all facets of Business Operations. Prior to joining Solesis, Gersen served as the Vice President of Global Operations for DSM Biomedical. His ability to relate easily across all functional areas and promote collaborative, team-based work environments will afford him the ability to achieve world-class performance at Solesis.

Gersen earned his Bachelor’s degree in Mechanical Engineering from the University at Buffalo and holds a Green Belt Certification in Training from Stryker.

Eric Shelton joined Solesis in 2024 as the Chief Commercial Officer. He is responsible for the full scope of the Commercial team, including Marketing and Product Development.

With more than 15 years of Commercial experience across the medical device and biopharmaceutical industries, Eric has an exceptional level of understanding of Solesis’ industries and expertise in creating and executing strategies to drive global business development and revenue growth. Most recently, he served as the Vice President, Global Commercial for DSM Biomedical. His forward-thinking leadership and customer-focused vision will position Solesis for continued growth.

Eric holds a Bachelor’s degree in Business Administration with an emphasis on Management from the University of North Carolina at Charlotte.

Brandon West joined Solesis in 2025 as the Chief Financial Officer. He is responsible for all financial aspects of Solesis and its family of companies, including financial planning, budgeting, forecasting, and accounting.

Brandon is a strategic finance executive with a strong track record of driving EBITDA growth, optimizing operational footprints, and executing Merger & Acquisition initiatives. He brings more than 20 years in capital management and operational efficiency. Prior to joining Solesis, Brandon served as the CFO of North America for Arcade Beauty. His expertise in working capital management and operational efficiency in leveraged environments is essential in leading the financial functions of Solesis.

Brandon earned an MBA from NYU’s Stern School of Business and Bachelor’s degree in Russian from the U.S. Military Academy at West Point. He is a veteran of the U.S. Army, where he served as a Company Grade Infantry Officer.

Marc Hendriks joined Solesis in 2024 as the VP, Corporate Development. He is responsible for identifying and evaluating potential strategic opportunities, partnerships, mergers, and acquisitions and leads the strategy, growth and expansion efforts, including R&D.

Marc is a hands-on and results-focused leader with a long track record of successful leadership experience in diverse business functions internationally. Marc has more than 30 years of experience and leadership across R&D and Business Development. Prior to joining Solesis, Marc served as the Vice President of Strategy & Business Development for DSM Biomedical. He brings a unique ability to drive business growth, while championing excellence programs in Quality, Security, Organizational Culture, Change Management, and Employee Engagement.

Marc earned his PhD from the Eindhoven University of Technology and an MBA from the Maastricht University School of Business and Economics. He has completed Executive Finance courses at the University of Pennsylvania’s Wharton School and Executive Leadership Programs through DSM’s Business Academy.